Diabetes drug shows success for heart failure patients: Manitoba study
A drug initially meant for treating diabetes is proving to be effective in helping heart failure patients lead longer and healthier lives, according to a recently published study from a Manitoba doctor.
St. Boniface Hospital cardiologist Dr. Shelley Zieroth enrolled patients in a phase three clinical trial called The Emperor-Preserved Trial which looked at the drug called Empagliflozin.
“It’s really quite a remarkable journey for this class of drugs,” Zieroth said. “Empagliflozin is known as an SGLT2 inhibitor which was originally tested in and proven to be beneficial as a blood glucose-lowering agent in individuals with type 2 diabetes.”
What this study did was test the drug in heart failure patients with preserved injection fraction. Dr. Zieroth described this as a type of heart failure where the pumping function of the heart is fine but the heart itself is very stiff.
“Until now, there really has been no effective therapies to improve long-term outcomes,” she said.
The findings from this study show that Empagliflozin resulted in a 21 per cent relative risk reduction in cardiovascular death or hospitalization for heart failure. Dr. Zieroth called this trial a landmark for both clinicians and patients.
“We know hospitalization for heart failure is a significant burden on the health-care system,” Zieroth said. “In fact, in patients over 65, it’s one of the top three causes of hospitalization.”
She said hospitalizations are where most of the money is spent on heart failure care, not the medications.
“Anything we can do to reduce heart failure hospitalizations thus has a positive impact on the health care system but also improves patient outcomes.”
The next step is to apply to Health Canada for rapid approval of this drug for this patient group.
CTVNews.ca Top Stories
'He's in our hearts': Family and friends still seek answers one year after Nathan Wise’s disappearance
It’s been a year since Nathan Wise went missing and his family is no closer to finding out what happened to him.
'My family doctor just fired me': Ontario patients frustrated with de-rostering
Dozens of Ontarians are expressing frustration in the province’s health-care system after their family doctors either dropped them as patients or threatened to after they sought urgent care elsewhere.
Ottawa pizzeria places among top 20 deep-dish pizzas in the world at international competition
An Ottawa pizzeria is being recognized as one of the top 20 deep-dish pizzas in the world.
Canada Post cracks down on Nunavut loophole to get free Amazon Prime shipping
Amazon's paid subscription service provides free delivery for online shopping across Canada except for remote locations, the company said in an email. While customers in Iqaluit qualify for the offer, all other communities in Nunavut are excluded.
Wildfire near Fort McMurray more than triples overnight, several evacuation alerts remain in place
The fire burning near Fort McMurray grew from 25 hectares to 5,500 hectares over the weekend.
Putin replaces Russian defence minister in rare cabinet shakeup
Russia’s President Vladimir Putin began a Cabinet shakeup on Sunday, proposing the replacement of Sergei Shoigu as defence minister as he begins his fifth term in office.
Man fatally 'slashed in the neck' in downtown Toronto, suspect outstanding
Police are searching for a male suspect after a man was “slashed in neck” on Sunday morning in downtown Toronto and died.
WATCH Dashcam video shows terrifying near-miss on two-lane northern Ontario highway
There were some scary moments for several people on a northern Ontario highway caught on video Thursday after a chain reaction following a truck fire.
Edibles, armchairs and adapters: Here are the recalls for this week
Health Canada announced various product recalls this week, including electric adapters, armchairs, cannabis edibles and vehicle components.